Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation.

Yusoh NA, Azil A, Alkilani AZ, Rahman MBA, Asmawi AA, Razali R, Adam F, Kamal NAMA

Open source

DOI
10.1208/s12249-026-03491-7
Published
2026 Jun 26
Container
AAPS PharmSciTech
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12249-026-03491-7,
  title = {Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation.},
  author = {Yusoh NA and Azil A and Alkilani AZ and Rahman MBA and Asmawi AA and Razali R and Adam F and Kamal NAMA},
  year = {2026},
  journal = {AAPS PharmSciTech},
  doi = {10.1208/s12249-026-03491-7},
  url = {https://doi.org/10.1208/s12249-026-03491-7}
}

RIS

TY  - JOUR
TI  - Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation.
AU  - Yusoh NA
AU  - Azil A
AU  - Alkilani AZ
AU  - Rahman MBA
AU  - Asmawi AA
AU  - Razali R
AU  - Adam F
AU  - Kamal NAMA
PY  - 2026
JO  - AAPS PharmSciTech
DO  - 10.1208/s12249-026-03491-7
UR  - https://doi.org/10.1208/s12249-026-03491-7
ER  - 

APA

NA, Y., A, A., AZ, A., MBA, R., AA, A., R, R., F, A., & NAMA, K. (2026). Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation.. AAPS PharmSciTech. https://doi.org/10.1208/s12249-026-03491-7

Source records